Christine J. Saoud

Array ( [id] => 847215 [patent_doc_number] => 07384915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Chimeric insulin-gad proteins for treating patients with type 1 diabetes or at risk of developing type 1 diabetes' [patent_app_type] => utility [patent_app_number] => 11/143947 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 12865 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384915.pdf [firstpage_image] =>[orig_patent_app_number] => 11143947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726918 [patent_doc_number] => 20060057678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Chimeric proteins for diagnosis and treatment of diabetes' [patent_app_type] => utility [patent_app_number] => 11/143966 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12850 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057678.pdf [firstpage_image] =>[orig_patent_app_number] => 11143966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5711235 [patent_doc_number] => 20060052580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Chimeric proteins for diagnosis and treatment of diabetes' [patent_app_type] => utility [patent_app_number] => 11/143943 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12855 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052580.pdf [firstpage_image] =>[orig_patent_app_number] => 11143943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534052 [patent_doc_number] => 07872016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Method for treating skeletal disorders resulting from FGFR malfunction' [patent_app_type] => utility [patent_app_number] => 11/597487 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 33 [patent_no_of_words] => 28237 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872016.pdf [firstpage_image] =>[orig_patent_app_number] => 11597487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085840 [patent_doc_number] => 20070275891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'OBG3 globular head and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/132814 [patent_app_country] => US [patent_app_date] => 2005-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 61640 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275891.pdf [firstpage_image] =>[orig_patent_app_number] => 11132814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4809173 [patent_doc_number] => 20080172751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Agent Comprising Fgf2 as an Effective Ingredient For Treatment or Prevention of Asthma and Chronic Obstructive Pulmonary Disease' [patent_app_type] => utility [patent_app_number] => 11/568896 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20080172751.pdf [firstpage_image] =>[orig_patent_app_number] => 11568896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111114 [patent_doc_number] => 20050208569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Human stanniocalcin-alpha' [patent_app_type] => utility [patent_app_number] => 11/125206 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11810 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208569.pdf [firstpage_image] =>[orig_patent_app_number] => 11125206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111114 [patent_doc_number] => 20050208569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Human stanniocalcin-alpha' [patent_app_type] => utility [patent_app_number] => 11/125206 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11810 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208569.pdf [firstpage_image] =>[orig_patent_app_number] => 11125206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259622 [patent_doc_number] => 20070213254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Remedy For Diabetic Neuropathy Comprising Gelatin Gel As Carrier' [patent_app_type] => utility [patent_app_number] => 11/547954 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4726 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213254.pdf [firstpage_image] =>[orig_patent_app_number] => 11547954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069482 [patent_doc_number] => 20050244867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Growth factor HTTER36' [patent_app_type] => utility [patent_app_number] => 11/091334 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18913 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244867.pdf [firstpage_image] =>[orig_patent_app_number] => 11091334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111097 [patent_doc_number] => 20050208552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Corpuscles of Stannius protein, stanniocalcin' [patent_app_type] => utility [patent_app_number] => 11/076158 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13355 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208552.pdf [firstpage_image] =>[orig_patent_app_number] => 11076158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7503512 [patent_doc_number] => 08034773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Immunostimulatory compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/588627 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15241 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034773.pdf [firstpage_image] =>[orig_patent_app_number] => 10588627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480632 [patent_doc_number] => 20090203589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'CHEMICALLY MODIFIED HUMAN GROWTH HORMONE RECEPTOR ANTAGONIST CONJUGATES' [patent_app_type] => utility [patent_app_number] => 11/815842 [patent_app_country] => US [patent_app_date] => 2005-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12725 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203589.pdf [firstpage_image] =>[orig_patent_app_number] => 11815842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589342 [patent_doc_number] => 08778880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Human growth hormone modified at position 35' [patent_app_type] => utility [patent_app_number] => 11/046432 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 80567 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11046432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7555467 [patent_doc_number] => 08067368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Vascular endothelial growth factors and methods of their use' [patent_app_type] => utility [patent_app_number] => 10/597509 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14662 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067368.pdf [firstpage_image] =>[orig_patent_app_number] => 10597509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331265 [patent_doc_number] => 20090111742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Use of fgf-21 and thiazolidinedione for treating type 2 diabetes' [patent_app_type] => utility [patent_app_number] => 10/587138 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5727 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111742.pdf [firstpage_image] =>[orig_patent_app_number] => 10587138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7005084 [patent_doc_number] => 20050170397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Novel receptors' [patent_app_type] => utility [patent_app_number] => 11/038360 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29209 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20050170397.pdf [firstpage_image] =>[orig_patent_app_number] => 11038360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 401119 [patent_doc_number] => 07291483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-06 [patent_title] => 'FGF-CX polynucleotide sequences and methods of producing same' [patent_app_type] => utility [patent_app_number] => 11/027948 [patent_app_country] => US [patent_app_date] => 2004-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 30556 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/291/07291483.pdf [firstpage_image] =>[orig_patent_app_number] => 11027948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408216 [patent_doc_number] => 07285534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Corticotropin-releasing hormone analogs and their uses' [patent_app_type] => utility [patent_app_number] => 11/006296 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5312 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285534.pdf [firstpage_image] =>[orig_patent_app_number] => 11006296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 352675 [patent_doc_number] => 07491697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Muteins of fibroblast growth factor 21' [patent_app_type] => utility [patent_app_number] => 10/579510 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8883 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491697.pdf [firstpage_image] =>[orig_patent_app_number] => 10579510 [rel_patent_id] =>[rel_patent_doc_number] =>)